After Flu Vaccine Mess, Chiron's Q3 Earnings 'Almost Irrelevant' Oct. 22, 2004 By Brady Huggett Chiron Corp. released its third-quarter earnings Wednesday, and while those figures were better than expected, the Fluvirin disaster has faded their importance. (BioWorld Today)Read More
